Prognostic factors in de novo metastatic renal cell carcinoma: A report from the latin american renal cancer group
dc.contributor.author | Abreu D. | |
dc.contributor.author | Decia R. | |
dc.contributor.author | Carvalhal G. | |
dc.contributor.author | Gueglio G. | |
dc.contributor.author | Tobia I. | |
dc.contributor.author | Garcia P. | |
dc.contributor.author | Zuñiga A. | |
dc.contributor.author | Meza L. | |
dc.contributor.author | Bengio R. | |
dc.contributor.author | Scorticati C. | |
dc.contributor.author | Castillejos R. | |
dc.contributor.author | Rodriguez F. | |
dc.contributor.author | Autran A.M. | |
dc.contributor.author | Gonzales C. | |
dc.contributor.author | Gadu J. | |
dc.contributor.author | Nolazco A. | |
dc.contributor.author | Ameri C. | |
dc.contributor.author | Zampolli H. | |
dc.contributor.author | Langenhin R. | |
dc.contributor.author | Muguruza D. | |
dc.contributor.author | Machado M.T. | |
dc.contributor.author | Mingote P. | |
dc.contributor.author | Yandian J. | |
dc.contributor.author | Clavijo J. | |
dc.contributor.author | Nogueira L. | |
dc.contributor.author | Clark O. | |
dc.contributor.author | Secin F. | |
dc.contributor.author | Rovegno A. | |
dc.contributor.author | Vilas A. | |
dc.contributor.author | Barrios E. | |
dc.contributor.author | Guimarães G. | |
dc.contributor.author | Zequi S.C. | |
dc.contributor.author | Glina S. | |
dc.contributor.author | Pal S.K. | |
dc.contributor.author | Rodriguez O. | |
dc.contributor.author | Palou J. | |
dc.contributor.author | Spiess P. | |
dc.contributor.author | Lara P.N. | |
dc.contributor.author | Marston Linehan W. | |
dc.contributor.author | Pastore A.L. | |
dc.date.accessioned | 2024-01-10T14:23:44Z | |
dc.date.available | 2024-01-10T14:23:44Z | |
dc.date.issued | 2021 | |
dc.description.abstract | © 2021 by American Society of Clinical Oncology.PURPOSE To assess the effect of clinical and pathological variables on cancer-specific and overall survival (OS) in de novo metastatic patients from a collaborative of primarily Latin American countries. PATIENTS AND METHODS Of 4,060 patients with renal cell carcinoma diagnosed between 1990 and 2015, a total of 530 (14.5%) had metastasis at clinical presentation. Relationships between clinical and pathological parameters and treatment-related outcomes were analyzed by Cox regression and the log-rank method. RESULTS Of 530 patients, 184 (90.6%) had died of renal cell carcinoma. The median OS of the entire cohort was 24 months. American Society of Anesthesiology classification 3-4 (hazard ratio [HR]: 1.64), perirenal fat invasion (HR: 2.02), and ≥ 2 metastatic organ sites (HR: 2.19) were independent prognostic factors for 5-year OS in multivariable analyses. We created a risk group stratification with these variables: no adverse risk factors (favorable group), median OS not reached; one adverse factor (intermediate group), median OS 33 months (HR: 2.04); and two or three adverse factors (poor risk group), median OS 14 months (HR: 3.58). CONCLUSION Our study defines novel prognostic factors that are relevant to a Latin American cohort. With external validation, these easily discerned clinical variables can be used to offer prognostic information across low- and middle-income countries. | |
dc.fechaingreso.objetodigital | 2024-05-15 | |
dc.fuente.origen | Scopus | |
dc.identifier.doi | 10.1200/GO.20.00621 | |
dc.identifier.eissn | 26878941 | |
dc.identifier.issn | 26878941 | |
dc.identifier.pubmedid | 33974442 | |
dc.identifier.scopusid | SCOPUS_ID:85105769181 | |
dc.identifier.uri | https://doi.org/10.1200/GO.20.00621 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/80135 | |
dc.information.autoruc | Facultad de Medicina; Rovegno Echavarria, David Maximiliano; S/I; 1004053 | |
dc.language.iso | en | |
dc.nota.acceso | Sin adjunto | |
dc.pagina.final | 685 | |
dc.pagina.inicio | 671 | |
dc.publisher | American Society of Clinical Oncology | |
dc.revista | JCO Global Oncology | |
dc.rights | registro bibliográfico | |
dc.title | Prognostic factors in de novo metastatic renal cell carcinoma: A report from the latin american renal cancer group | |
dc.type | artículo de revisión | |
dc.volumen | 7 | |
sipa.codpersvinculados | 1004053 | |
sipa.index | Scopus | |
sipa.index | Pubmed | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- abreu-et-al-2021-prognostic-factors-in-de-novo-metastatic-renal-cell-carcinoma-a-report-from-the-latin-american-renal.pdf
- Size:
- 795.47 KB
- Format:
- Adobe Portable Document Format
- Description: